Keyphrases
Methotrexate
100%
Recurrent Glioblastoma
100%
Ventricular Cerebrospinal Fluid
27%
Steady State
18%
Folate
18%
Bioactive
18%
Brain Tumor
18%
Continuous Infusion
18%
Clinical Trials
9%
Tumor
9%
Delivery System
9%
Oral Administration
9%
Therapeutic Approaches
9%
Cerebrospinal Fluid
9%
Serum Levels
9%
Glioblastoma multiforme
9%
Pneumonia
9%
Brain Tissue
9%
Tumor Size
9%
Hepatitis
9%
Systemic Toxicity
9%
Patient Variables
9%
Autopsy
9%
Seizure Frequency
9%
Fluid Level
9%
Clinical Examination
9%
Radiological Study
9%
Central Nervous System Toxicity
9%
Tumor Bed
9%
Viable Tumor
9%
Infusion Devices
9%
Folinic Acid
9%
Pharmacology, Toxicology and Pharmaceutical Science
Glioblastoma
100%
Methotrexate
100%
Neoplasm
36%
Folic Acid
18%
Intracranial Tumor
18%
Clinical Trial
9%
Necrosis
9%
Recurrent Disease
9%
Folinic Acid
9%
Neuroscience
Methotrexate
100%
Necrosis
9%
Central Nervous System
9%
Glioblastoma Multiforme
9%
Folinic Acid
9%